PharmaTher Holdings Ltd.

PharmaTher Holdings Ltd.verified

PHRRF

Price:

$0.166

Market Cap:

$20.54M

PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company's product in pipeline includes Ketamine intravenous injection, which is in Phase II and III clinical trials for Parkinson's disease, anesthesia and sedation, and amyotrophic lateral sclerosis indications. Its pipeline also comprises Ketamine Patch that is in Phase I and II clinical trials for treating depression, mental health, complex regional pain syndrome, and pain disorders; and Ketamine Pump, which is in Phase II clinical...[Read more]

Industry

Biotechnology

IPO Date

2021-01-08

Stock Exchange

PNK

Ticker

PHRRF

The PE Ratio as of November 2024 (TTM) for PharmaTher Holdings Ltd. (PHRRF) is -4.15

According to PharmaTher Holdings Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -4.15. This represents a change of -61.43% compared to the average of -10.76 of the last 4 quarters.

PharmaTher Holdings Ltd. (PHRRF) Historical PE Ratio (quarterly & annually)

How has PHRRF PE Ratio performed in the past?

The mean historical PE Ratio of PharmaTher Holdings Ltd. over the last ten years is -70.27. The current -4.15 PE Ratio has changed 490.56% with respect to the historical average. Over the past ten years (40 quarters), PHRRF's PE Ratio was at its highest in in the May 2021 quarter at 95.22. The PE Ratio was at its lowest in in the November 2021 quarter at -55.83.

Quarterly (TTM)
Annual

Average

-70.27

Median

-2.76

Minimum

-349.39

Maximum

8.47

PharmaTher Holdings Ltd. (PHRRF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of PharmaTher Holdings Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 297.15%

Maximum Annual PE Ratio = 8.47

Minimum Annual Increase = -132.55%

Minimum Annual PE Ratio = -349.39

Quarterly (TTM)
Annual
YearPE RatioChange
2024-6.14297.15%
2023-1.55-43.92%
2022-2.76-132.55%
20218.47-102.43%

PharmaTher Holdings Ltd. (PHRRF) Average PE Ratio

How has PHRRF PE Ratio performed in the past?

The current PE Ratio of PharmaTher Holdings Ltd. (PHRRF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.48

5-year avg

-70.27

10-year avg

-70.27

PharmaTher Holdings Ltd. (PHRRF) PE Ratio vs. Peers

How is PHRRF’s PE Ratio compared to its peers?

PharmaTher Holdings Ltd.’s PE Ratio is less than Adial Pharmaceuticals, Inc. (-0.45), less than TransCode Therapeutics, Inc. (-0.38), less than Aditxt, Inc. (-0.00), less than Reviva Pharmaceuticals Holdings, Inc. (-1.19), less than Avenue Therapeutics, Inc. (-0.23), less than Tryp Therapeutics Inc. (0), less than PsyBio Therapeutics Corp. (-2.16), less than Awakn Life Sciences Corp. (-0.00), less than XOMA Corporation (-1.75), greater than Fortress Biotech, Inc. (-11.81), less than Checkpoint Therapeutics, Inc. (-0.62), less than ZIVO Bioscience, Inc. (-3.48), greater than Lumos Pharma, Inc. (-5.20), less than Wesana Health Holdings Inc. (-1.03), less than BioVaxys Technology Corp. (-0.22), less than GH Research PLC (-3.14), greater than Algernon Pharmaceuticals Inc. (-11.64), less than AXIM Biotechnologies, Inc. (-0.74), less than Regen BioPharma, Inc. (-0.16), less than Regen BioPharma, Inc. (-0.41), less than Mymetics Corporation (-0.43), less than ProtoKinetix, Incorporated (-0.00), greater than null (-9.22),

Build a custom stock screener for PharmaTher Holdings Ltd. (PHRRF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PharmaTher Holdings Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PharmaTher Holdings Ltd. (PHRRF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PharmaTher Holdings Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is PharmaTher Holdings Ltd.'s PE Ratio?

How is the PE Ratio calculated for PharmaTher Holdings Ltd. (PHRRF)?

What is the highest PE Ratio for PharmaTher Holdings Ltd. (PHRRF)?

What is the 3-year average PE Ratio for PharmaTher Holdings Ltd. (PHRRF)?

What is the 5-year average PE Ratio for PharmaTher Holdings Ltd. (PHRRF)?

How does the current PE Ratio for PharmaTher Holdings Ltd. (PHRRF) compare to its historical average?